Hepatitis
for December 5, 2011
SUMMARY AND COMMENT
Investigators report progress in using histologic data to more accurately distinguish between the two conditions.
Reviewing: Suzuki A et al. Hepatology 2011 Sep 54:931
SUMMARY AND COMMENT
At
7 years of follow-up, about 20% of patients with NAFLD developed liver
complications and 13% died or received a transplant. Adjusted outcomes
were favorable compared with similar patients with HCV infection.
Reviewing: Bhala N et al. Hepatology 2011 Oct 54:1208
SUMMARY AND COMMENT
Clinicians
should assess whether patients receiving bariatric surgery for obesity
have cirrhosis and, if so, possibly refer them to a high-volume center
for the procedure.
Reviewing: Mosko JD and Nguyen GC. Clin Gastroenterol Hepatol 2011 Oct 9:897
FEATURE
Dr. Paul Sax reviews the "breathtaking" results just presented at The Liver Meeting, in his blog HIV and ID Observations.
SUMMARY AND COMMENT
Adding N-acetylcysteine
to glucocorticoid therapy did not improve 6-month survival. Early liver
transplant did, but in a selectively chosen subgroup.
Reviewing: Nguyen-Khac E et al. N Engl J Med 2011 Nov 10; 365:1781
Mathurin P et al. N Engl J Med 2011 Nov 10; 365:1790
Brown RS Jr. N Engl J Med 2011 Nov 10; 365:1836
Free Full-Text Article
|
Summary and Comment
Histologic Features Can Differentiate Drug-Induced Liver Injury from Autoimmune Hepatitis
Investigators report progress in using histologic data to more accurately distinguish between the two conditions.
The
clinical scenario of a patient who presents with acute hepatitis on
potentially hepatotoxic medications, with negative viral serologies but
low-level autoimmune markers, can be challenging. The difficulty lies
in determining whether the patient has drug-induced liver injury
(DILI), for which there is no specific treatment, or autoimmune
hepatitis (AIH), for which immunosuppressants are indicated. To date,
histologic findings have generally not been helpful.
To explore possible differences in histologic profiles that could
improve diagnostic accuracy, four experienced hepatopathologists
conducted detailed, blinded reviews of 63 liver biopsies of clinically
well-characterized cases of AIH and DILI. All were reviewed from
clinical and histologic standpoints to verify diagnoses.
Concordance of clinical diagnosis
with histologic diagnosis was 65%. However, among the four
hepatopathologists, complete agreement on histologic diagnosis was only
46%. Based on statistical modeling, several histologic characteristics
predicted DILI versus AIH: portal inflammation, portal plasma cells,
intra-acinar lymphocytes and eosinophils, rosette formation, and
canalicular cholestasis (area under the curve, 0.9). Specifically, the
presence of intra-acinar lymphocytes and canalicular cholestasis
favored DILI, whereas the presence of rosette formation, portal plasma
cells, and severe portal inflammation favored AIH. Of note, the
presence of intra-acinar eosinophils, which has been regarded as one of
the histologic findings suggesting DILI, was more frequently seen in
AIH in this cohort.
Comment: Results should be interpreted with caution because
of the small sample size, and because even experts frequently disagreed
on histologic diagnosis. Nonetheless, a larger study to assess
interobserver variation and cross-validate these findings should be
performed. Histologic criteria such as these that reliably
differentiate DILI from AIH would be extremely useful in clinical
practice.
— Atif Zaman, MD, MPH
Published in Journal Watch Gastroenterology December 2, 2011
Citation(s):
Suzuki
A et al. The use of liver biopsy evaluation in discrimination of
idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology
2011 Sep; 54:931.
|
|
|
No hay comentarios:
Publicar un comentario